BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Stahl M, Kim TK, Zeidan AM. Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities. World J Stem Cells 2016; 8(10): 316-331 [PMID: 27822339 DOI: 10.4252/wjsc.v8.i10.316]
URL: https://www.wjgnet.com/1948-0210/full/v8/i10/316.htm
Number Citing Articles
1
Mahdi Pakjoo, Seyed Esmaeil Ahmadi, Mohammad Zahedi, Niloofar Jaafari, Reyhane Khademi, Ali Amini, Majid Safa. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitorsCell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-023-01433-5
2
Chi H. Nguyen, Alexander M. Grandits, Louise E. Purton, Heinz Sill, Rotraud Wieser. All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cellsCell Cycle 2020; 19(20): 2573 doi: 10.1080/15384101.2020.1810402
3
Ziqi Feng, Zelin Wang, Yun Yang, Yuzhi Du, Sixin Cui, Yi Zhang, Yanan Tong, Zhen Song, Hao Zeng, Quanming Zou, Liusheng Peng, Hongwu Sun. Development of a safety and efficacy nanoemulsion delivery system encapsulated gambogic acid for acute myeloid leukemia in vitro and in vivoEuropean Journal of Pharmaceutical Sciences 2018; 125: 172 doi: 10.1016/j.ejps.2018.10.001
4
Luyun Peng, Yuanting Tang, Yingchi Zhang, Siqi Guo, Leiwen Peng, Lei Ye, Yuefang Wang, Yongmei Jiang. Structural maintenance of chromosomes 4 is required for leukemia stem cell maintenance in MLL-AF9 induced acute myeloid leukemiaLeukemia & Lymphoma 2018; 59(10): 2423 doi: 10.1080/10428194.2017.1387906
5
Chi Huu Nguyen, Alexander M. Grandits, George S. Vassiliou, Philipp B. Staber, Gerwin Heller, Rotraud Wieser. Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia CellsBiomedicines 2020; 8(10): 385 doi: 10.3390/biomedicines8100385
6
Alexander M. Grandits, Rotraud Wieser. Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6AExperimental Hematology 2021; 99: 1 doi: 10.1016/j.exphem.2021.05.004
7
Matthew Masoudi, Vinod Gopalan. Cancer Stem Cells: Basic Concept and Therapeutic Implications2023; : 149 doi: 10.1007/978-981-99-3185-9_9
8
Jan Philipp Bewersdorf, Maximilian Stahl, Amer M. Zeidan. Are we witnessing the start of a therapeutic revolution in acute myeloid leukemia?Leukemia & Lymphoma 2019; 60(6): 1354 doi: 10.1080/10428194.2018.1546854
9
Jan Philipp Bewersdorf, Rory M. Shallis, Rong Wang, Scott F. Huntington, Sarah Perreault, Xiaomei Ma, Amer M. Zeidan. Healthcare expenses for treatment of acute myeloid leukemiaExpert Review of Hematology 2019; 12(8): 641 doi: 10.1080/17474086.2019.1627869
10
Lindsay Wilde, Sabarina Ramanathan, Margaret Kasner. B-cell lymphoma-2 inhibition and resistance in acute myeloid leukemiaWorld Journal of Clinical Oncology 2020; 11(8): 528-540 doi: 10.5306/wjco.v11.i8.528
11
Maximilian Stahl, Benjamin Y. Lu, Tae Kon Kim, Amer M. Zeidan. Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?Targeted Oncology 2017; 12(4): 413 doi: 10.1007/s11523-017-0503-8
12
Maria De Grandis, Florence Bardin, Cyril Fauriat, Christophe Zemmour, Abdessamad El-Kaoutari, Arnauld Sergé, Samuel Granjeaud, Laurent Pouyet, Camille Montersino, Anne-Sophie Chretien, Marie-Joelle Mozziconacci, Remy Castellano, Ghislain Bidaut, Jean-Marie Boher, Yves Collette, Stéphane J.C. Mancini, Norbert Vey, Michel Aurrand-Lions. JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid LeukemiaCancer Research 2017; 77(23): 6627 doi: 10.1158/0008-5472.CAN-17-1223
13
Cristina Mambet, Mihaela Chivu-Economescu, Lilia Matei, Laura Georgiana Necula, Denisa Laura Dragu, Coralia Bleotu, Carmen Cristina Diaconu. Murine models based on acute myeloid leukemia-initiating stem cells xenograftingWorld Journal of Stem Cells 2018; 10(6): 57-65 doi: 10.4252/wjsc.v10.i6.57
14
Ran Li, Xiaolu Wu, Kai Xue, Junmin Li. ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemiaCancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02684-x
15
Mingxue Fan, Minghao Li, Lipeng Gao, Sicong Geng, Jing Wang, Yiting Wang, Zhiqiang Yan, Lei Yu. Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemiaJournal of Hematology & Oncology 2017; 10(1) doi: 10.1186/s13045-017-0519-7